About: Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
Creator	Comi, Giancarlo Dobson, Richard Hotopf, Matthew Leocani, Letizia Magyari, Melinda Cummins, Nicholas Dalla Costa, Gloria Guerrero, Ana Montalban, Xavier Narayan, Vaibhav Per, & Sørensen, Soelberg
source	Medline; PMC
abstract	We assessed the prevalence and impact of COVID-19 among multiple sclerosis (MS) patients across Europe by leveraging participant data collected as part of the ongoing EU IMI2 RADAR-CNS major programme aimed at finding new ways of monitoring neurological disorders using wearable devices and smartphone technology. In the present study, 399 patients of RADAR-MS have been included (mean age 43.9 years, 60.7% females) with 87/399 patients (21.8%) reporting major symptoms suggestive of COVID-19. A trend for an increased risk of COVID-19 symptoms under alemtuzumab and cladribine treatments in comparison to injectables was observed. Remote monitoring technologies may support health authorities in monitoring and containing the ongoing pandemic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10072-020-04519-x) contains supplementary material, which is available to authorized users.
has issue date	2020-07-02(xsd:dateTime)
bibo:doi	10.1007/s10072-020-04519-x
bibo:pmid	32617741
has license	no-cc
sha1sum (hex)	82f6fd0876d5e9ba20af2f8101ca15da41ca7512
schema:url	https://doi.org/10.1007/s10072-020-04519-x
resource representing a document's title	Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
has PubMed Central identifier	PMC7331489
has PubMed identifier	32617741
schema:publication	Neurol Sci
resource representing a document's body	covid:82f6fd0876d5e9ba20af2f8101ca15da41ca7512#body_text
is schema:about of	named entity 'smartphone' named entity 'ongoing' named entity 'symptoms' named entity 'Europe' named entity 'patients' named entity 'multicenter' named entity 'MULTIPLE SCLEROSIS' named entity 'INCLUDED' named entity 'TREATMENTS' named entity 'PANDEMIC' named entity 'HEALTH' named entity 'INJECTABLES' named entity 'OBSERVED' named entity 'MONITORING' named entity 'ONGOING' named entity 'PROGRAMME' named entity 'PRESENT' named entity 'SUGGESTIVE OF' named entity 'COVID-19' named entity 'pandemic' named entity 'risk' named entity 'neurological disorders' named entity 'patients' named entity 'collected' named entity 'COVID-19' named entity 'alemtuzumab' named entity 'COVID-19' named entity 'consortium' named entity 'multiple sclerosis' named entity 'COVID-19 disease' named entity 'cough' named entity 'COVID' named entity 'morbidity' named entity 'working from home' named entity 'COVID' named entity 'infection' named entity 'SARS-CoV-2' named entity 'questionnaire' named entity 'anti-CD20' named entity 'evolution' named entity 'ageusia' named entity 'cladribine' named entity 'COVID' named entity 'dimethyl fumarate' named entity 'cladribine' named entity 'China' named entity 'World Health Organization' named entity 'glatiramer acetate' named entity 'COVID-19' named entity 'interferons' named entity 'anosmia' named entity 'infection' named entity 'relapsing-remitting' named entity 'alemtuzumab' named entity 'anosmia' named entity 'dimethyl fumarate' named entity 'COVID-19' named entity 'disability' named entity 'COVID' named entity 'X-ray' named entity 'COVID' named entity 'COVID' named entity 'anosmia' named entity 'COVID' named entity 'COVID' named entity 'signs/symptoms' named entity 'COVID' named entity 'physical tests' named entity 'COVID' named entity 'March 2020'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software